跳至主要内容
临床试验/NCT02069067
NCT02069067进行中(未招募)不适用

Multicenter Observational Study of the Incidence and Treatment Modalities of Breakthrough Cancer Pain in Patients With Chronic Cancer Pain

National Cancer Institute, Naples3 个研究点 分布在 1 个国家目标入组 500 人开始时间: 2011年12月最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
500
试验地点
3
主要终点
treatments used to treat BTcP

研究概览

简要总结

The purpose of this study is to describe how often advanced cancer patients experience breakthrough pain (BTcP), and to describe how this pain is treated, and how effective these treatments are.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Diagnosis of neoplasm in advanced stage
  • Chronic pain controlled for at least one week with opioids 60 mg / day morphine equivalent
  • 1-6 episodes of BTcP within any of 3 days previous to registration into study
  • Signed Informed Consent

排除标准

  • · More than 6 episodes of BTcP within any of 3 days previous to registration into study

结局指标

主要结局

treatments used to treat BTcP

时间窗: one year

number of patients who experience BTcP

时间窗: one year

次要结局

  • time to pain relief of BTcP(4 weeks)
  • effective dose for BTcP(4 weeks)
  • initial dose of therapy (in morphine equivalents) for BTcP(4 weeks)
  • pain intensity(4 weeks)

研究者

发起方
National Cancer Institute, Naples
申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验